[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354252-105":59,"doc-detail-354252-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","suv-family-histone-methyltransferases-correlate-with-nuclear-lamina-remodeling-and-clinical-outcome-in-cancer-integrative-pan-cancer-tcga-analysis-and-experimental-evidence","SUV family histone methyltransferases correlate with nuclear lamina remodeling and clinical outcome in cancer - integrative pan-cancer TCGA analysis and experimental evidence","","Epigenetic control of chromatin architecture drives transcription and nuclear organization in cancer. SUV39H1 and SUV39H2 catalyze H3K9me3, promoting repressive heterochromatin that supports genomic stability, yet their pan-cancer expression patterns, prognostic impact, and structural links remain unclear. Using integrative TCGA analysis plus experimental validation, the study shows SUV39H2 overexpression across multiple tumors and strong association with poor survival in high-grade serous ovarian cancer, coupled with reduced immune infiltration and correlations with nuclear lamina genes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/suv-family-histone-methyltransferases-correlate-with-nuclear-lamina-remodeling-and-clinical-outcome-in-cancer-integrative-pan-cancer-tcga-analysis-and-experimental-evidence/354252/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/suv-family-histone-methyltransferases-correlate-with-nuclear-lamina-remodeling-and-clinical-outcome-in-cancer-integrative-pan-cancer-tcga-analysis-and-experimental-evidence/354252.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do SUV39H1 and SUV39H2 play in chromatin regulation?","Question",{"text":112,"@type":113},"They catalyze trimethylation of histone H3 at lysine 9 (H3K9me3), forming repressive heterochromatin domains that support genomic stability and nuclear organization.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does SUV39H2 expression relate to clinical outcome in cancer?",{"text":117,"@type":113},"SUV39H2 is overexpressed across multiple tumor types, and higher SUV39H2 levels correlate with poor overall survival, particularly in high-grade serous ovarian cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the relationship between SUV39H2 and the immune microenvironment?",{"text":121,"@type":113},"High SUV39H2 expression is inversely associated with tumor-infiltrating lymphocytes, indicating reduced immune infiltration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354252,1790255090,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSUV family histone methyltransferases correlate with nuclear lamina remodeling  \nand clinical outcome in cancer: integrative pan-cancer TCGA analysis and experimental evidence  \nSubhadip Kundu1, Abdur Rahmaan Akhtar1, Arun Kumar2 & Ashok Sharma1,3􀀍  \nEpigenetic regulation of chromatin structure is a key determinant of transcriptional control and nuclear organization in cancer. Among histone lysine methyltransferases, SUV39H1 and SUV39H2 catalyze the trimethylation of histone H3 lysine 9 (H3K9me3), establishing repressive heterochromatin domains that are important for genomic stability. However, their pan-cancer expression dynamics, prognostic value, and structural implications remain poorly defined. In this study, we performed an integrative analysis of SUV39H1 and SUV39H2 across the Cancer Genome Atlas (TCGA) cohort to investigate their expression, prognostic relevance, associations with the immune landscape, and interactions with nuclear lamina genes. Both enzymes were significantly overexpressed in multiple tumor types, with SUV39H2 showing particularly high expression in high-grade serous ovarian cancer (HGSOC), where elevated levels correlated with poor overall survival (HR = 3.27, p \u003C 0.001) . Immune infiltration analysis revealed that high SUV39H2 expression was inversely associated with tumor-infiltrating lymphocytes, indicating reduced immune infiltration. Correlation studies demonstrated strong positive associations between SUV39H1/H2 and Lamin B genes (LMNB1, LMNB2), suggesting an association with nuclear lamina–linked heterochromatin. Conversely, LaminA (LMNA) exhibited weak or negative correlation with SUV39 enzymes. Functional validation inA2780 ovarian cancer cells demonstrated that pharmacological inhibition of SUV39H2 by Chaetocin resulted in the upregulation of LaminA, suggesting that SUV39H1/H2 inhibition is associated with LaminA regulation. Collectively, our findings uncover a previously underappreciated association between SUV39H2, chromatin–lamina interactions, and immune evasion in ovarian cancer, highlighting SUV39H2 as a potential chromatin-associated biomarker and regulator of nuclear organization and providing a rationale for targeting SUV39H2 in therapeutic epigenetic interventions.  \nKeywords SUV39H2, H3K9me3, Ovarian cancer, Lamin A, Epigenetic repression, Immune evasion  \nEpigenetic modifications play a central role in regulating chromatin structure, transcriptional dynamics, and genome stability 1,2. Among the diverse set of chromatin-modifying enzymes, histone lysine methyltransferases (KMTs) establish and maintain transcriptionally permissive or repressive chromatin states by depositing specific methyl groups on histone tails 3,4. One of the most critical histone modifications associated with transcriptional repression is the trimethylation of histone H3 at lysine 9 (H3K9me3) . This repressive mark is enriched in constitutive heterochromatin regions, repetitive DNA elements, and lamina-associated domains (LADs), thereby contributing to nuclear compartmentalization, gene silencing, and chromosomal integrity 5,6. The establishment of this mark is largely mediated by the Suppressor of Variegation (SUV) family of histone methyltransferases, which includes SUV39H1, SUV39H2, and closely related enzymes 7.  \n1Laboratory of Chromatin and Cancer Epigenetics, Department of Biochemistry, AIIMS, New Delhi 110029, India.  \n2Mahavir Cancer Sansthan and Research Centre, Patna, Bihar, India. 3National Cancer Institute, AIIMS, Jhajjar, Haryana, India. 􀀍 email: [ashok.sharma@aiims.edu](ashok.sharma@aiims.edu)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nThe SUV family is evolutionarily conserved and has been studied extensively for its role in heterochromatin formation. SUV39H1 was initially identified in Drosophila as a key regulator of position-effect variegation 8 and later shown in mammals to be ","cbCaiswCKBaM1neY","https://ap.wps.com/l/cbCaiswCKBaM1neY","pdf",3760917,18,"English","# Epigenetic background: H3K9me3 and SUV39 enzymes\n## SUV39H1 and SUV39H2 functions in heterochromatin\n# Integrative pan-cancer TCGA analysis\n## Expression and prognostic relevance\n## Associations with immune landscape\n## Correlation with nuclear lamina genes\n# Experimental validation in ovarian cancer cells\n## Pharmacological inhibition of SUV39H2 and Lamin regulation\n# Conclusions and therapeutic implications","[{\"question\":\"What role do SUV39H1 and SUV39H2 play in chromatin regulation?\",\"answer\":\"They catalyze trimethylation of histone H3 at lysine 9 (H3K9me3), forming repressive heterochromatin domains that support genomic stability and nuclear organization.\"},{\"question\":\"How does SUV39H2 expression relate to clinical outcome in cancer?\",\"answer\":\"SUV39H2 is overexpressed across multiple tumor types, and higher SUV39H2 levels correlate with poor overall survival, particularly in high-grade serous ovarian cancer.\"},{\"question\":\"What is the relationship between SUV39H2 and the immune microenvironment?\",\"answer\":\"High SUV39H2 expression is inversely associated with tumor-infiltrating lymphocytes, indicating reduced immune infiltration.\"}]","SUV family histone methyltransferases correlate with nuclear lamina remodeling and clinical outcome in cancer - integrative pan-cancer TCGA analysis and experimental evidence | PDF",1790109729,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/708bb3faac0f9fc8101739dd6cb62714.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8a7030c644b541785717d330ea451c9.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5837432cb1a27a89fc947dbf7e303f4.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ab43c84d5f229bd6e0d34b6d4e035b8.webp",980,1287]